Next Article in Journal
RNA Therapeutics in Viral Infections and Cancer: Mechanisms, Challenges, and Prospects: A Review
Previous Article in Journal
pH-Responsive Nanostructured Calcium Phosphate Microrods as Pulmonary Delivery Platform: Fabrication, Characterization, and Comparative Assessment of Cytotoxic and Transcriptomic Responses in Alveolar Macrophages
Previous Article in Special Issue
Facial Skin Density Enhancement Using Hyaluronic Acid—Based Bioactive Hydrogel: Cannula-Assisted Delivery and Ultrasound Evaluation in a Retrospective Controlled Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmaceutics
Volume 18
Issue 4
10.3390/pharmaceutics18040429
pharmaceutics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evidence-Based Translational Strategy of Medicated Topical Gel for Diabetic Wound Management

by
Poonam Pal
1,
Santosh Kumar
1,
Ankita Yadav
1,
Salil Dubey
2,
Sanchit Arora
3,
Sanjay Kumar
3,
Mayank Gangwar
4,
Anurag Mishra
1,
Amaresh Kumar Singh
2,
Shreyans K. Jain
3,
Ashish Kumar Agrawal
3,
Satyanam Kumar Bhartiya
5 and
Sanjeev Kumar
1,*
1
Department of Dravyaguna, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India
2
Department of Zoology, Institute of Sciences, Banaras Hindu University, Varanasi 221005, India
3
Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India
4
Clinical Studies and Trials Unit, Development Division, Indian Council of Medical Research, New Delhi 110029, India
5
Department of General Surgery, Faculty of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221005, India
*
Author to whom correspondence should be addressed.
Pharmaceutics 2026, 18(4), 429; https://doi.org/10.3390/pharmaceutics18040429
Submission received: 14 February 2026 / Revised: 9 March 2026 / Accepted: 27 March 2026 / Published: 31 March 2026
(This article belongs to the Special Issue New Perspectives in Hydrogel Design for Medicine and Biotechnology)
Browse Figures
Versions Notes

Abstract

Background: Chronic diabetic wounds represent substantial issues in healthcare due to their poor healing rate and susceptibility to hyperglycemia, infections, and other serious consequences. Methods: In this work, we developed a Medicated Topical Gel (MTG) that promotes healing of diabetic wounds. The MTG’s distinctive qualities, including biocompatibility, stability, affordability, cost-effectiveness, and non-toxicity, were evaluated in a dermal toxicity assessment as well as a diabetic wound assay from 0 to the 24th day of the study. Results: MTG treatment significantly accelerated wound closure compared with other formulations. In vivo studies revealed that diabetic wounds in the rat model healed more rapidly within the 24-day study period when treated with MTG. Western blot analysis revealed a significant decrease in pro-inflammatory markers, accompanied by enhanced angiogenesis, which was further confirmed by histopathological observations. These findings indicate that MTG effectively promotes faster wound healing by modulating inflammation and stimulating blood vessel formation. Furthermore, clinical cases have demonstrated substantial wound healing, with most cases showing significant recovery on follow-up intervals at 15th and 30th day. Conclusions: Our findings demonstrate a strong evidence-based therapeutic potential of MTG as an effective treatment for chronic diabetic wounds healing. They also provide a promising strategy for wound management in both the experimental and clinical case studies.
Keywords: diabetic wound healing; medicated topical gel; dermal toxicity; markers diabetic wound healing; medicated topical gel; dermal toxicity; markers
Graphical Abstract

Share and Cite

MDPI and ACS Style

Pal, P.; Kumar, S.; Yadav, A.; Dubey, S.; Arora, S.; Kumar, S.; Gangwar, M.; Mishra, A.; Singh, A.K.; Jain, S.K.; et al. Evidence-Based Translational Strategy of Medicated Topical Gel for Diabetic Wound Management. Pharmaceutics 2026, 18, 429. https://doi.org/10.3390/pharmaceutics18040429

AMA Style

Pal P, Kumar S, Yadav A, Dubey S, Arora S, Kumar S, Gangwar M, Mishra A, Singh AK, Jain SK, et al. Evidence-Based Translational Strategy of Medicated Topical Gel for Diabetic Wound Management. Pharmaceutics. 2026; 18(4):429. https://doi.org/10.3390/pharmaceutics18040429

Chicago/Turabian Style

Pal, Poonam, Santosh Kumar, Ankita Yadav, Salil Dubey, Sanchit Arora, Sanjay Kumar, Mayank Gangwar, Anurag Mishra, Amaresh Kumar Singh, Shreyans K. Jain, and et al. 2026. "Evidence-Based Translational Strategy of Medicated Topical Gel for Diabetic Wound Management" Pharmaceutics 18, no. 4: 429. https://doi.org/10.3390/pharmaceutics18040429

APA Style

Pal, P., Kumar, S., Yadav, A., Dubey, S., Arora, S., Kumar, S., Gangwar, M., Mishra, A., Singh, A. K., Jain, S. K., Agrawal, A. K., Bhartiya, S. K., & Kumar, S. (2026). Evidence-Based Translational Strategy of Medicated Topical Gel for Diabetic Wound Management. Pharmaceutics, 18(4), 429. https://doi.org/10.3390/pharmaceutics18040429

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop